EICHOR
● Recruiting
Periprosthetic Joint Infection Bubble Study
Condition: Periprosthetic Joint Infection (PJI) · Sponsor: Thomas Jefferson University
About this study
Patients with an infected knee replacement will receive their standard of care surgical treatment of the infection, with and without additional ultrasound microbubble treatment (randomly divided 50/50 in the active and control groups). Subjects in the active group will receive a local bolus injection of antibiotics and ultrasound-active microbubbles within 24 hours of their revision surgery. The fundamental hypothesis is that a decrease in re-infection rates of at least 24% can be achieved in the active group relative to controls.
This description comes directly from the study's public registry record.
Talk to the study team
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
Locations (3)
| Thomas Jefferson University/Rothman Institute | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Pittsburgh Medical Center (UPMC) | Pittsburgh, Pennsylvania, United States | Not Yet Recruiting |
| UT Southwestern Medical Center | Dallas, Texas, United States | Not Yet Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07599865